Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Induced protein degradation: An emerging drug discovery paradigm
Ashton C. Lai
, Craig M. Crews
Research output
:
Contribution to journal
›
Review article
›
peer-review
1205
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Induced protein degradation: An emerging drug discovery paradigm'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Drug Exposure
100%
Protein Function
100%
Drug Discovery
100%
Systemic Medications
100%
Emerging Drugs
100%
Induced Protein Degradation
100%
Target Molecule
50%
Protein Expression
50%
Regulatory Proteins
50%
Pharmaceutical Industry
50%
Small Molecules
50%
Binding Site
50%
Scaffold Protein
50%
Targeted Inhibition
50%
Cellular Quality Control
50%
Technology-based
50%
Occupancy
50%
Proteolysis Targeting chimera (PROTAC)
50%
Drug Binding
50%
Off-target Effects
50%
Small-molecule Drug Discovery
50%
Transcription Factor Proteins
50%
Biochemistry, Genetics and Molecular Biology
Small Molecule
100%
Protein Function
100%
Protein Catabolism
100%
Drug Exposure
100%
Drug Development
100%
Binding Site
50%
Transcription Factors
50%
Protein Expression
50%
Quality Control
50%
Targeting Protein
50%
Drug Binding
50%
Proteolysis
50%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
100%
Binding Site
50%
Regulator Protein
50%
Elimination
50%
Transcription Factors
50%
Scaffold Protein
50%